News Scotland says yes to Truvada as PrEP The Scottish Medicines Consortium has approved the use of Gilead’s Truvada for use in preventing new HIV infections, so called pre-exposure prophylaxis (PrEP).
News NHS England confirms HIV prevention funding - but only via c... Large trial of HIV PrEP could lead to national programme
News Gilead donates Truvada to HIV trial patients PROUD trial patients can continue treatment for six months.
News EU approves Gilead's Truvada for HIV prevention But there are funding problems in UK, Australia and Canada.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
